High-Level Expression and Novel Antifungal Activity of Mouse Beta Defensin-1 Mature Peptide in Escherichia coli

被引:0
作者
Yueling Wang
Yan Jiang
Tianxiang Gong
Xiaoyan Cui
Wanyi Li
Yan Feng
Baoning Wang
Zhonghua Jiang
Mingyuan Li
机构
[1] Sichuan University,Department of Microbiology, West China School of Preclinical and Forensic Medicine
[2] Sichuan University,Department of Biochemistry and Molecular Biology, West China Medical Center
[3] Sichuan University,State Key Laboratory of Oral Diseases
来源
Applied Biochemistry and Biotechnology | 2010年 / 160卷
关键词
Mouse beta defensin-1; Soluble expression; Fusion protein; Purification; Antifungal activity;
D O I
暂无
中图分类号
学科分类号
摘要
Mouse beta defensin-1 (mBD-1) is a cationic 37-amino acid antimicrobial peptide with three conserved cysterine disulfied bonds. It exhibits a broad antimicrobial spectrum, but mBD-1 against Candida albicans (C. albicans) and Cryptococcus neoformans (C. neoformans) is poorly understood. This study describes the mBD-1 gene, the heterologous fusion expression of the peptide in Escherichia coli, and the bioactive assay of released mature mBD-1. By constructing the expression plasmid (pET32a-mBD1), high yields of soluble mBD-1 fusion protein (0.67 g/L) could be obtained in E. coli and cleaved by enterokinase. The digested product was further purified and desalted with the final amount of pure mature mBD-1 being 0.14 g/L. Classical fungi growth inhibition assay showed clear antifungal activity against C. albicans and C. neoformans with IC50 of 5 and 2 μM, respectively. The results show that the mBD-1 control fungal colonization through hyphal induction, direct fungicidal activity, and the activity is suppressed by increasing NaCl concentration. Successful expression of the mBD-1 peptide in E. coli offers a basis for further studying its antifungal mechanisms and may provide significance in developing this peptide to an antifungal drug.
引用
收藏
页码:213 / 221
页数:8
相关论文
共 46 条
[1]  
Ganz T.(1994)undefined Current Opinion in Immunology 6 584-589
[2]  
Lehrer R. I.(1998)undefined Mammalian Genome 9 453-457
[3]  
Morrison G. M.(2002)undefined Infection and Immunity 70 3068-3072
[4]  
Davidson D. J.(1998)undefined The Journal of Biological Chemistry 273 20438-20447
[5]  
Kilanowski F. M.(2003)undefined Antimicrobial Agents and Chemotherapy 47 3305-3310
[6]  
Moser C.(2006)undefined Biotechnology Letters 28 1101-1108
[7]  
Weiner D. J.(2006)undefined Antimicrobial Agents and Chemotherapy 50 324-331
[8]  
Lysenko E.(1995)undefined Biochemistry 34 13663-13671
[9]  
Edgerton M.(2000)undefined Methods in Enzymology 326 322-340
[10]  
Koshlukova S. E.(1993)undefined The Journal of Biological Chemistry 268 19239-19245